Clinical Endocannabinoid Deficiency was a theory posited by Dr. Russo back in 2001 in which he theorized that low endocannabinoid levels could be behind a range of chronic conditions such as IBS, fibromyalgia, migraines, and other treatment-resistant syndromes. Dr. Russo suggested that because these conditions are all developed over time, rather than congenitally, and that they could be a result of disturbances to the ECS. This also means there’s a possibility of reversing them.
Authoritarians cannot let go of the value that keeping the most widely used illicit substance…
No need to wait until May—April showers bring dank flowers for every strain. A big…
One of the men was aged 59 years old; he bought bat poop online to…
Paradise Seeds has been charming critics and customers for decades, and now home growers in…
Leafly sat down with Ulysses Youngblood, founder of Major Bloom dispensary in Worcester Massachusetts, to…
Edible Arrangements, a brand renowned for its vibrant fruit bouquets and sweet treats, is embarking…
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
